Dr. M Reza Movahed received his MD from Medizinische Hochschule Hannover, Germany. He completed his medical residency at the University of Rochester, New York and his cardiology training at the University of South Caroline, Columbia. His final training in interventional cardiology was completed at Yale University Hospital, New Haven, Connecticut in 2000. After his training, he joined University of California Irvine as Assistant Clinical Professor and later joined University of Arizona College of Medicine in 2006 as Associate Professor of Medicine, Division of Cardiology. In July 2010, Dr. Movahed was promoted to Professor of Medicine, Tenure at the University Of Arizona College Of Medicine due to his excellent clinical work, teaching, service and research with over 200 peer reviewed publications. He has been Director of Cardiac Catheterization Laboratory and Nuclear Cardiology at the University of California, Irvine medical Center and Director of Coronary Care Unit and Medical Director of Cardiac Transplantation at the University of Arizona Medical Center. In 2007, he joined the Southern Arizona VA Health Care System for his clinical work and as the Medical Director of Heart Transplantation. In May 2012, he joined CareMore as The Regional Cardiology Director of CareMore in Arizona while keeping his teaching and research affiliation with the VA and the University of Arizona as Professor of Medicine, tenure. His major area of research is related to coronary intervention, non-invasive cardiology and cardiovascular epidemiology. He is world-renowned for his coronary bifurcation classification known as “The Movahed Classification” He is also known for his discovery on the flattening of interventricular septum as a sign for right ventricular overload the so called “ Movahed’s sign” that can be seen during Gated SPECT studied and recently published reverse “Movahed Maneuver” that can be used for improvement of stent deliverability during difficult and tortuous vein graft interventions. He also has two cardiovascular patents issued to him. One is a device for removal of contrast from coronary sinus during coronary angiography or intervention in order to reduce contrast exposure to kidneys for prevention of contrast induced nephropathy. The other one is a method and device that can measure cross sectional lumen of a vessel using impedance sensors. His publications include prestige’s journals such as New England Journal of Medicine, Nature Reviews, Circulation, American Journal of Medicine, Journal of American College of Cardiology, American Heart Journal, American Journal of Cardiology, Journal of Society of Echocardiography, JACC cardiovascular Intervention, JACC Imaging, Catheterization and Cardiovascular Intervention, Journal of Invasive cardiology, Journal of Interventional Cardiology, etc. He is an editorial board member of numerous peer reviewed journals. He has been invited speaker and chair for many national and international cardiology conventions and conferences. He has been Board Certified in Internal Medicine, and Echocardiography and currently certified in cardiovascular disease, Advanced Heart failure/Transplantation, Nuclear Cardiology and Interventional Cardiology.

His research interests are Coronary Disease, Interventional Cardiology, Nuclear Cardiology, non-invasive cardiology and cardiovascular epidemiology